Oncolytics Biotech Inc.
NASDAQ:ONCYBiotechnology
Healthcare
$0.50 +3.03%
+$0.03 today
- Market cap
- $50.41M
- Beta
- 1.08
- P/E (TTM)
- -4.3
- EPS (TTM)
- -$0.32
52W Low $0.56High $1.51
Volume 0.38M
Average 1.26M
Balance Sheet
Inspect the capital base behind the business.
Assets
$10.40M
FY 2025 · Annual
-48.5% YoYLiabilities
$15.62M
FY 2025 · Annual
+9.9% YoYEquity
-$5.21M
FY 2025 · Annual
Balance Sheet
CAD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 41.26M | 11.67M | 34.91M | 15.94M | 7.14M |
| Short-term Investments | 0 | 20.47M | 0 | 0 | 0 |
| Net Receivables | 866K | 521K | 15K | 68K | 786.23K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 980K | 0 |
| Total Current Assets | 44.9M | 35.68M | 38.17M | 18.88M | 9.39M |
| Property, Plant & Equipment (Net) | 976K | 652K | 647K | 1.31M | 1.01M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 998K | 0 | 0 | 0 |
| Total Non-current Assets | 976K | 1.65M | 647K | 1.31M | 1.01M |
| Total Assets | 45.88M | 37.33M | 38.82M | 20.19M | 10.4M |
| Account Payables | 594K | 2.25M | 1.08M | 1.09M | 4.81M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 408K | 79K | 532K | 1.62M | 3.3M |
| Total Current Liabilities | 2.69M | 3.95M | 4.24M | 6.69M | 8.37M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 6.73M | 6.73M | 6.73M | 6.73M | 6.74M |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 7.09M | 6.89M | 7.02M | 7.52M | 7.24M |
| Total Liabilities | 9.78M | 10.83M | 11.26M | 14.2M | 15.62M |
| Common Stock | 391.35M | 404.04M | 430.91M | 438.19M | 0 |
| Retained Earnings | (393.42M) | (418.25M) | (446M) | (477.71M) | (589.32M) |
| Accumulated OCI | 388K | 662K | 544K | 961K | 8.54M |
| Other Stockholders Equity | 3.62M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 36.1M | 26.5M | 27.56M | 5.98M | (5.21M) |
| Total Debt | 655K | 373K | 423K | 1.06M | 772.51K |
| Net Debt | (40.61M) | (11.29M) | (34.49M) | (14.88M) | (6.37M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $5.5M |
| Receivables | $961.0K |
| Other Current | $1.0M |
| Total Current Assets | $7.5M |
| PP&E (Net) | $674.0K |
| Total Non-current Assets | $674.0K |
| Total Assets | $8.2M |
Analysis
Selected assets total $8.2M for Latest. The largest visible component is Cash & Equivalents at $5.5M, about 67.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 20, 2026 | |
| 8-K | Current report | Oct 14, 2026 | |
| 8-K | Current report | Oct 13, 2026 | |
| DEFA14A | DEFA14A filing | Oct 6, 2026 | |
| DEF 14A | DEF 14A filing | Oct 6, 2026 |
How much cash does ONCY have?
Oncolytics Biotech Inc. (ONCY) reported $7.14M in cash and equivalents in fiscal 2025.
How much debt does ONCY carry?
Oncolytics Biotech Inc. (ONCY) reported $772,509.00 of total debt, with net debt of -$6.37M.
Continue the stock analysis
Jump to another research area for this company.